A restrospective analysis of toxicities encountered with palliative epirubicin, oxaliplatin, and capecitabine (EOX) chemotherapy for advanced esophagogastric cancer.

被引：1
|
作者：
Khakoo, Shelize Sadrudin [1 ]
Georgiou, Alexandros [1 ]
Waters, Justin S. [1 ]
机构：
[1] Kent Oncol Ctr, Maidstone, Kent, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.162
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
162
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tolerability ol epirubicin, oxaliplatin, and capecitabine chemotherapy in advanced esophagogastric cancer.
    Rigby, Christina
    Evans, Marion
    Chan, Kevin
    Spencer-Shaw, Andrea
    Owen-Holt, Vikki
    Mansoor, Wasat
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Locally advanced gastric cancer treated with neoadjuvant chemotherapy: Epirubicin, oxaliplatin, and capecitabine (EOX)
    Pluschnig, U.
    Zacherl, J.
    Schoppmann, S.
    Raderer, M.
    Prager, G.
    Bartsch, R.
    Ba-Ssalamah, A.
    Lamm, W.
    Zielinski, C.
    Hejna, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [3] Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer.
    Cunningham, David
    Okines, Alicia F. C.
    Ashley, Sue
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (09): : 858 - 859
  • [4] Epirubicin, Oxaliplatin & Capecitabine Combination for Untreated Advanced Esophagogastric Cancer
    Alam, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S466 - S467
  • [5] Neoadjuvant chemotheraphy in locally advanced gastric cancer with epirubicin, oxaliplatin, and capecitabine (EOX): A retrospective analysis
    Pluschnig, U.
    Zacherl, J.
    Schoppmann, S.
    Raderer, M.
    Prager, G.
    Bartsch, R.
    Ba-Ssalamah, A.
    Lamm, W.
    Zielinski, C.
    Hejna, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as Palliative First-line Chemotherapy for Gastroesophageal Adenocarcinoma
    Pluschnig, Ursula
    Schoppmann, Sebastian F.
    Preusser, Matthias
    Datler, Philip
    Asari, Reza
    Ba-Ssalamah, Ahmed
    Schwameis, Katrin
    Birner, Peter
    Zacherl, Johannes
    Hejna, Michael
    [J]. ANTICANCER RESEARCH, 2013, 33 (03) : 1035 - 1039
  • [7] Capecitabine and oxaliplatin for advanced esophagogastric cancer
    Cunningham, David
    Starling, Naureen
    Rao, Sheela
    Iveson, Timothy
    Nicolson, Marianne
    Coxon, Fareeda
    Middleton, Gary
    Daniel, Francis
    Oates, Jacqueline
    Norman, Andrew Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01): : 36 - 46
  • [8] A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma
    Petersen, Peter C.
    Petersen, Lone N.
    Vogelius, Ivan
    Bjerregaard, Jon K.
    Baeksgaard, Lene
    [J]. ACTA ONCOLOGICA, 2021, 60 (07) : 948 - 953
  • [9] Randomised phase II trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma (SEED)
    Petersen, P. C.
    Petersen, L. Noergaard
    Vogelius, I. R.
    Bjerregaard, J. K.
    Baeksgaard, L.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [10] Capecitabine and oxaliplatin for advanced esophagogastric cancer - Reply
    Perrotta, Silverio
    Della Ragione, Fulvio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18): : 1966 - 1966
12345